![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » CHUGAI TO MANUFACTURE TAMIFLU DRY SYRUP IN JAPAN
CHUGAI TO MANUFACTURE TAMIFLU DRY SYRUP IN JAPAN
Chugai Pharmaceutical Co. Ltd. (Chugai) has decided to manufacture a modified version of Tamiflu Dry Syrup 3 percent in Japan. Tamiflu Dry Syrup is a dry syrup formulation of the anti-influenza drug Oseltamivir that Chugai imports from F. Hoffmann-La Roche Ltd. (Roche) for production and marketing in Japan. BioSpectrum (http://www.biospectrumasia.com/content/200706JPN1176.asp)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct